Sr. Director​/Director, Business Development & Corporate Strategy; Remote

Job Summary

The Sr. Director of Business Development & Corporate Strategy will drive company growth through strategic partnerships, licensing, and corporate development initiatives. This role requires an experienced biotech or pharmaceutical business development leader with a track record of advancing innovative, late‑stage (Phase II/III), first‑in‑class assets. The Senior Director will lead global opportunity sourcing, diligence, and deal execution, while partnering cross‑functionally to evaluate international assets and collaborations, support CDMO business development, and engage with financial investment partners.

• Identify, evaluate, and lead strategic transactions and investments aligned with business strategy, including first‑in‑class and differentiated therapeutic modalities (e.g., complex platforms).
• Biotech Business Development & Asset Acquisition
  • Lead the search, evaluation, and acquisition of innovative clinical‑to‑commercial‑stage therapeutic assets, with emphasis on late‑stage (Phase II/III), first‑in‑class programs aligned with Dendreon’s core therapeutic areas, including immunotherapy, urology, and oncology.
• CDMO Strategy & Business Development
  • Build and execute a business development plan to position manufacturing capabilities as a CDMO partner for emerging and established biotech clients.
• Deal Structuring, Negotiation & Execution
  • Lead the structuring, negotiation, and execution of term sheets and definitive agreements for BD and CDMO transactions.
• Executive Strategy & Portfolio Planning
  • Partner with the CEO and Senior Leadership Team to refine corporate strategy and long‑range planning.

• Required Experience & Skills
  • 7-10+ years of progressive experience in business development in the biotech or pharmaceutical industry.
  • Demonstrated ability to lead BD, M&A, licensing, or investment transactions from sourcing through execution.
  • Advanced degree required: MBA, PhD, MD, or equivalent scientific or financial training.
  • Strong understanding of complex therapeutic modalities, such as ADCs, biologics, cell therapies, or other advanced platforms.
  • Deep financial acumen including valuation modeling, risk/return analysis, and deal structuring.
  • Executive presence and excellent communication skills with ability to build trust internally and externally.
  • Strong cross‑functional leadership with proven ability to influence stakeholders across Clinical, Technical Ops, Regulatory, and Legal.